Daily Market Reports | Mar 25 2026
This story features ATLANTIC LITHIUM LIMITED., and other companies.
For more info SHARE ANALYSIS: A11
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
A11 ALL ARX AUE BRG BTL BTR CNB CTM HVN JBH LNW MAF MYR PME PMV SM1 SNZ TPG WES
A11 ATLANTIC LITHIUM LIMITED.
New Battery Elements – Overnight Price: $0.29
Canaccord Genuity rates ((A11)) as Speculative Buy (1) –
Atlantic Lithium has announced the full ratification of the mining lease for the Ewoyaa lithium project by the Ghana government. The company can now advance project funding and FID.
The next steps will be reporting on the second half optimisation in order to enhance economics amid periods of commodity price volatility.
Canaccord Genuity considers the ratification a significant positive for the company. Speculative Buy rating and 37p target unchanged.
This report was published on March 20, 2026.
Current Price is $0.29. Target price not assessed.
Market Sentiment: -1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ALL ARISTOCRAT LEISURE LIMITED
Gaming – Overnight Price: $45.61
Jarden rates ((ALL)) as Buy (1) –
Jarden highlights a growing North American legislative pipeline supporting multi-year earnings upside for Aristocrat Leisure. It’s felt expanding addressable markets and regulatory complexity reinforce structural barriers to entry, benefiting incumbent operators.
The broker notes progress across land-based gaming, iGaming and iLottery, with new state openings and capacity additions underpinning growth opportunities.
Competitive positioning remains strong, in the analysts’ view, given proprietary content and regulatory moats, limiting disruption risks and supporting long-term earnings visibility.
The $68 target and Buy rating are maintained.
This report was published on March 24, 2026.
Target price is $68.00 Current Price is $45.61 Difference: $22.39
If ALL meets the Jarden target it will return approximately 49% (excluding dividends, fees and charges).
Current consensus price target is $67.31, suggesting upside of 44.9%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 105.00 cents and EPS of 260.30 cents.
At the last closing share price the estimated dividend yield is 2.30%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 260.4, implying annual growth of 13.6%.
Current consensus DPS estimate is 95.4, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 17.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 115.00 cents and EPS of 286.50 cents.
At the last closing share price the estimated dividend yield is 2.52%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.92.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 292.1, implying annual growth of 12.2%.
Current consensus DPS estimate is 106.0, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 15.9.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ARX AROA BIOSURGERY LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.58
Canaccord Genuity rates ((ARX)) as Buy (1) –
Canaccord Genuity notes the first 80 days of CMS payment reform for skin substitutes in the US has meant product has been “dumped” into the market.
Major manufacturers such as Aroa Biosurgery are having to put up with this, and the broker notes they have responded by ramping up evidence quality and direct sales support.
Canaccord Genuity points out the company’s Symphony is set to enter the “skinsub” fray as a “good guy”, providing a reasonably priced efficacious option.
Buy rating. Target is raised to $1.16 from $0.90.
This report was published on March 24, 2026.
Target price is $1.16 Current Price is $0.58 Difference: $0.58
If ARX meets the Canaccord Genuity target it will return approximately 100% (excluding dividends, fees and charges).
The company’s fiscal year ends in March.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.89 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 65.17.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AUE AURUM RESOURCES LIMITED
Gold & Silver – Overnight Price: $0.53
Canaccord Genuity rates ((AUE)) as Speculative Buy (1) –
Perseus Mining ((PRU)) has invested -$23.7m in Aurum Resources for a 9.9% stake.
Canaccord Genuity considers the investment strategically significant as it highlights potential synergies between Perseus’ Sissingue operation and Bagoe tenure with the Boundiali gold project in northern Cote d’Ivoire.
The company has secured $28.8m in a strategic placement of 48m shares at $0.60 each, strengthening its balance sheet to over $60m in cash.
Overall, the broker believes the capital raising endorses the project and the Perseus investment materially de-risks the development pathway. Speculative Buy rating and $1.55 target.
This report was published on March 23, 2026.
Target price is $1.55 Current Price is $0.53 Difference: $1.025
If AUE meets the Canaccord Genuity target it will return approximately 195% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BRG BREVILLE GROUP LIMITED
Household & Personal Products – Overnight Price: $26.03
Jarden rates ((BRG)) as Overweight (2) –
Jarden highlights AI and replacement cycles as potential upside drivers for IT and consumer electronics demand, despite a challenging macro backdrop. Replacement activity is expected to add 6%-9% to sales, with peak demand expected across FY26–FY27.
The broker believes OEM price increases, particularly from memory cost inflation, may support sales growth, though volume risks remain from higher prices.
Upside potential is strongest for JB Hi-Fi and Harvey Norman, according to Jarden, with AI adoption and device proliferation supporting multi-year demand growth.
The broker also expects Wesfarmers, via Officeworks, and Breville Group to benefit.
Target of $34.90 and Overweight rating are kept for Breville Group.
This report was published on March 23, 2026.
Target price is $34.90 Current Price is $26.03 Difference: $8.87
If BRG meets the Jarden target it will return approximately 34% (excluding dividends, fees and charges).
Current consensus price target is $38.67, suggesting upside of 43.0%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 38.00 cents and EPS of 94.80 cents.
At the last closing share price the estimated dividend yield is 1.46%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 27.46.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 97.7, implying annual growth of 3.4%.
Current consensus DPS estimate is 38.4, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 27.7.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 44.00 cents and EPS of 106.60 cents.
At the last closing share price the estimated dividend yield is 1.69%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.42.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 111.0, implying annual growth of 13.6%.
Current consensus DPS estimate is 42.5, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 24.4.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BTL BEETALOO ENERGY AUSTRALIA LIMITED
Energy – Overnight Price: $0.23
Canaccord Genuity rates ((BTL)) as Speculative Buy (1) –
Canaccord Genuity reinstates coverage of Beetaloo Energy Australia, which is the dominant player and holder of acreage in the Beetaloo Basin.
The business has transitioned to a near-term producer following FID in December 2025, targeting first sales out of the Carpentaria pilot project by the end of 2026.
If the pilot proves commercial, the broker expects the majors to move quickly and the company has a strategic foothold and first mover advantage. Speculative Buy rating and $0.45 target.
This report was published on March 24, 2026.
Target price is $0.45 Current Price is $0.23 Difference: $0.215
If BTL meets the Canaccord Genuity target it will return approximately 91% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BTR BRIGHTSTAR RESOURCES LIMITED
Gold & Silver – Overnight Price: $0.33
Canaccord Genuity rates ((BTR)) as Speculative Buy (1) –
Brightstar Resources has updated the definitive feasibility study for the Menzies-Laverton field, outlining average production of 75,000ozpa at AISC of $2998/oz over an initial six-year mine life.
The updated DFS envisages treating ore from Menzies and Laverton by the new plant.
Canaccord Genuity aligns its modelling with the outcomes of the updated DFS, incorporating higher operating and capital expenditure assumptions as well as a more conservative timeline to first production.
Speculative Buy rating unchanged. Target is reduced to $2.40 from $2.80.
This report was published on March 23, 2026.
Target price is $2.40 Current Price is $0.33 Difference: $2.07
If BTR meets the Canaccord Genuity target it will return approximately 627% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CNB CARNABY RESOURCES LIMITED
Mining – Overnight Price: $0.36
Moelis rates ((CNB)) as Buy (1) –
Moelis highlights new drilling at Carnaby Resources’ Trekelano deposit, confirming continuity of high-grade mineralisation and potential extension at depth.
These results support the prospect of expanding the resource and adding underground development potential below the current open pit, the analyst explains.
Commentary notes the breccia shoot is now defined over a 600m down-plunge extent, reinforcing confidence in the broader Greater Duchess project.
Management’s development focus remains on advancing the feasibility study, the final investment decision (FID) and near-term production pathway supported by low capital intensity. explains Moelis.
Unchanged Buy rating and 90c target.
This report was published on March 25, 2026.
Target price is $0.90 Current Price is $0.36 Difference: $0.535
If CNB meets the Moelis target it will return approximately 147% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 11.06.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CTM CENTAURUS METALS LIMITED
Nickel – Overnight Price: $0.53
Canaccord Genuity rates ((CTM)) as Speculative Buy (1) –
Centaurus Metals has received a US$190m Letter of Intent (LOI) from Brazil’s development bank, marking a key step toward funding the Jaguar Nickel Project, Canaccord Genuity highlights.
Commentary outlines the facility has potential to cover around half of pre-production capex, with additional funding options including equity, offtake prepayments or project sell-down.
The broker notes the LOI follows a binding offtake agreement with Glencore, supporting project credibility and financing progression ahead of the final investment decision (FID) targeted for September 2026.
Canaccord retains a Speculative Buy rating and 85c target.
This report was published on March 24, 2026.
Target price is $0.85 Current Price is $0.53 Difference: $0.32
If CTM meets the Canaccord Genuity target it will return approximately 60% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 106.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 1.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 44.17.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HVN HARVEY NORMAN HOLDINGS LIMITED
Consumer Electronics – Overnight Price: $4.97
Jarden rates ((HVN)) as Overweight (2) –
Jarden highlights AI and replacement cycles as potential upside drivers for IT and consumer electronics demand, despite a challenging macro backdrop.
Replacement activity is expected to add 6%-9% to sales, with peak demand expected across FY26–FY27.
The broker believes OEM price increases, particularly from memory cost inflation, may support sales growth, though volume risks remain from higher prices.
Upside potential is strongest for JB Hi-Fi and Harvey Norman, according to Jarden, with AI adoption and device proliferation supporting multi-year demand growth.
The broker also expects Wesfarmers, via Officeworks, and Breville Group to benefit.
Target of $6.60 and Overweight rating are kept for Harvey Norman.
This report was published on March 23, 2026.
Target price is $6.60 Current Price is $4.97 Difference: $1.63
If HVN meets the Jarden target it will return approximately 33% (excluding dividends, fees and charges).
Current consensus price target is $6.54, suggesting upside of 30.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 26.00 cents and EPS of 37.50 cents.
At the last closing share price the estimated dividend yield is 5.23%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.25.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 38.2, implying annual growth of -8.1%.
Current consensus DPS estimate is 29.6, implying a prospective dividend yield of 5.9%.
Current consensus EPS estimate suggests the PER is 13.1.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 29.00 cents and EPS of 42.90 cents.
At the last closing share price the estimated dividend yield is 5.84%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 41.0, implying annual growth of 7.3%.
Current consensus DPS estimate is 32.5, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 12.2.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
JBH JB HI-FI LIMITED
Consumer Electronics – Overnight Price: $73.67
Jarden rates ((JBH)) as Overweight (2) –
Jarden highlights AI and replacement cycles as potential upside drivers for IT and consumer electronics demand, despite a challenging macro backdrop.
Replacement activity is expected to add 6%-9% to sales, with peak demand expected across FY26–FY27.
The broker believes OEM price increases, particularly from memory cost inflation, may support sales growth, though volume risks remain from higher prices.
Upside potential is strongest for JB Hi-Fi and Harvey Norman, according to Jarden, with AI adoption and device proliferation supporting multi-year demand growth.
The broker also expects Wesfarmers, via Officeworks, and Breville Group to benefit.
Target of $88.90 and Overweight rating are kept for JB Hi-Fi.
This report was published on March 23, 2026.
Target price is $88.90 Current Price is $73.67 Difference: $15.23
If JBH meets the Jarden target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $91.28, suggesting upside of 21.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 441.00 cents and EPS of 466.20 cents.
At the last closing share price the estimated dividend yield is 5.99%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.80.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 459.9, implying annual growth of 8.7%.
Current consensus DPS estimate is 346.1, implying a prospective dividend yield of 4.6%.
Current consensus EPS estimate suggests the PER is 16.4.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 363.00 cents and EPS of 496.00 cents.
At the last closing share price the estimated dividend yield is 4.93%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.85.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 480.8, implying annual growth of 4.5%.
Current consensus DPS estimate is 363.5, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 15.7.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
LNW LIGHT & WONDER INC
Gaming – Overnight Price: $117.00
Jarden rates ((LNW)) as Buy (1) –
Jarden highlights a growing North American legislative pipeline supporting multi-year earnings upside for Light & Wonder.
It’s felt expanding addressable markets and regulatory complexity reinforce structural barriers to entry, benefiting incumbent operators.
The broker notes progress across land-based gaming, iGaming and iLottery, with new state openings and capacity additions underpinning growth opportunities.
Competitive positioning remains strong, in the analysts’ view, given proprietary content and regulatory moats, limiting disruption risks and supporting long-term earnings visibility.
The $199 target and Buy rating are maintained.
This report was published on March 24, 2026.
Target price is $199.00 Current Price is $117.00 Difference: $82
If LNW meets the Jarden target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is $202.50, suggesting upside of 63.6%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 1184.31 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.88.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 1050.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 11.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 1394.82 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.39.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 1234.2, implying annual growth of 17.5%.
Current consensus DPS estimate is 70.4, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 10.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MAF MA FINANCIAL GROUP LIMITED
Wealth Management & Investments – Overnight Price: $7.00
Jarden rates ((MAF)) as Initiation of coverage with Overweight (2) –
Jarden initiates coverage of MA Financial with an Overweight rating and $9.45 target. The share price has pulled back over the year to date and makes for an attractive entry point, in the broker’s opinion.
Driving this pullback included broader negative sentiment around the private credit space driven out of the US.
At this point, domestically there are few signs of stress, yet Jarden considers it worth watching from a fund flows point of view.
Commentary concludes the business has multiple earnings drivers and MA Money has easily surpassed expectations with book growth in excess of 100%.
This report was published on March 22, 2026.
Target price is $9.45 Current Price is $7.00 Difference: $2.45
If MAF meets the Jarden target it will return approximately 35% (excluding dividends, fees and charges).
Current consensus price target is $11.28, suggesting upside of 51.2%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 45.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 48.0, implying annual growth of 669.2%.
Current consensus DPS estimate is 27.8, implying a prospective dividend yield of 3.7%.
Current consensus EPS estimate suggests the PER is 15.5.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 55.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.73.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 58.0, implying annual growth of 20.8%.
Current consensus DPS estimate is 33.6, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 12.9.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MYR MYER HOLDINGS LIMITED
Household & Personal Products – Overnight Price: $0.29
Canaccord Genuity rates ((MYR)) as Buy (1) –
Myer’s 1H26 result was broadly in line with Canaccord Genuity’s expectations with stronger cost control offset by softer trading through December and January.
Underlying momentum remains intact, suggests the analyst, supported by improving brand execution, exclusive ranges and loyalty initiatives.
The broker highlights cost-of-doing-business (CODB) pressures are easing, with second-half improvement expected from better sell-through and customer engagement strategies.
The broker’s earnings revisions reflect higher promotional activity, though balance sheet strength and cash flow remain supportive.
Target falls to 73c from 79c. Buy rating unchanged.
This report was published on March 24, 2026.
Target price is $0.73 Current Price is $0.29 Difference: $0.44
If MYR meets the Canaccord Genuity target it will return approximately 152% (excluding dividends, fees and charges).
The company’s fiscal year ends in July.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 2.00 cents and EPS of 3.70 cents.
At the last closing share price the estimated dividend yield is 6.90%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.84.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 3.00 cents and EPS of 4.50 cents.
At the last closing share price the estimated dividend yield is 10.34%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.44.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PME PRO MEDICUS LIMITED
Medical Equipment & Devices – Overnight Price: $119.53
Moelis rates ((PME)) as Upgrade to Buy from Hold (1) –
Moelis upgrades Pro Medicus to Buy from Hold although acknowledges macro risks will overhang the stock in the near term while the long-term outlook is unchanged with strong growth rates likely continuing for a number of years.
The broker points out the share price since the first half result has fallen a further -6%, largely related to macro events that are beyond management’s control.
The report also states it is important to note this is not a cyclical business and customers are largely insulated from the impacts of higher oil prices. Target is $145.03.
This report was published on March 24, 2026.
Target price is $145.03 Current Price is $119.53 Difference: $25.5
If PME meets the Moelis target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $259.00, suggesting upside of 112.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 67.00 cents and EPS of 138.10 cents.
At the last closing share price the estimated dividend yield is 0.56%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 86.55.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 185.4, implying annual growth of 68.1%.
Current consensus DPS estimate is 67.8, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 65.9.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 96.00 cents and EPS of 191.80 cents.
At the last closing share price the estimated dividend yield is 0.80%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 62.32.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 187.1, implying annual growth of 0.9%.
Current consensus DPS estimate is 89.8, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 65.3.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PMV PREMIER INVESTMENTS LIMITED
Apparel & Footwear – Overnight Price: $12.32
Jarden rates ((PMV)) as Upgrade to Overweight from Neutral (2) –
Premier Investments delivered a first half result that was in line with expectations. The main issue for Jarden is whether FY26 EBIT guidance is achievable when provided so early in the half and whether Smiggle can recover.
With a new CEO for Smiggle having been announced and a renewed focus on product, the broker concludes the company can stabilise the business.
Market expectations appear low yet, while headwinds are building in terms of interest-rate hikes and petrol prices, Jarden assesses the stock is insulated with an active buyback, management alignment and net cash.
Rating is upgraded to Overweight from Neutral. Target is reduced to $15.50 from $16.90.
This report was published on March 20, 2026.
Target price is $15.50 Current Price is $12.32 Difference: $3.18
If PMV meets the Jarden target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $17.53, suggesting upside of 35.4%(ex-dividends)
The company’s fiscal year ends in July.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 89.20 cents and EPS of 101.70 cents.
At the last closing share price the estimated dividend yield is 7.24%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.11.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 97.7, implying annual growth of -5.8%.
Current consensus DPS estimate is 77.2, implying a prospective dividend yield of 6.0%.
Current consensus EPS estimate suggests the PER is 13.3.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 90.60 cents and EPS of 107.00 cents.
At the last closing share price the estimated dividend yield is 7.35%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 109.7, implying annual growth of 12.3%.
Current consensus DPS estimate is 83.2, implying a prospective dividend yield of 6.4%.
Current consensus EPS estimate suggests the PER is 11.8.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SM1 SYNLAIT MILK LIMITED
Dairy – Overnight Price: $0.41
Jarden rates ((SM1)) as Underweight (4) –
Synlait Milk delivered a weak operating performance in the first half, the culmination of a series of inventory manufacturing challenges, Jarden observes.
The loss was driven by higher costs for manufacturing plant adjustments and lower ingredients returns.
Jarden reiterates an Underweight rating, finding it difficult to forecast earnings given the volatility in the business, and ahead of a strategy re-set.
The main risks include management execution, demand from a2 Milk ((A2M)) and the NZ dollar and commodity price volatility. Target is steady at NZ$0.45.
This report was published on March 23, 2026.
Current Price is $0.41. Target price not assessed.
Current consensus price target is $0.72, suggesting upside of 80.0%(ex-dividends)
The company’s fiscal year ends in July.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 8.99 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 4.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -4.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.78 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.03.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 2.4, implying annual growth of N/A.
Current consensus DPS estimate is 1.1, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 16.7.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SNZ SUMMERSET GROUP HOLDINGS LIMITED
Aged Care & Seniors – Overnight Price: $7.78
Jarden rates ((SNZ)) as Neutral (3) –
Jarden highlights operating costs as a key opportunity for Summerset, noting improved efficiency and transparency could reduce forecasting risk and enhance valuation outcomes.
Costs represent around 90% of revenue, highlight the analysts, making them a critical but under-disclosed driver of earnings and valuation sensitivity.
The broker points to current limited cost visibility and disclosure, with inconsistency versus peers, undermining confidence in forecasts and valuation assumptions.
Valuation risk remains elevated given sensitivity to cost trajectories, house price growth and leverage, notes Jarden.
Neutral rating and target of NZ$11.44 are maintained.
This report was published on March 24, 2026.
Current Price is $7.78. Target price not assessed.
Current consensus price target is N/A
The company’s fiscal year ends in December.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 4.27 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 182.12.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 92.1, implying annual growth of N/A.
Current consensus DPS estimate is 20.7, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 8.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 2.76 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 281.99.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 100.3, implying annual growth of 8.9%.
Current consensus DPS estimate is 21.2, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 7.9.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TPG TPG TELECOM LIMITED
Telecommunication – Overnight Price: $4.03
Jarden rates ((TPG)) as Overweight (2) –
TPG Telecom has increased the front-book prepaid prices of Vodafone and Lebara by 7-14%, Jarden notes.
Data allowances generally have also increased. At the prepaid portfolio level, Jarden estimates the price changes will drive a 3% ARPU uplift, largely in line with 2026 expectations.
The broker assesses the industry’s ability to align prices with value across all segments is crucial to further repairing returns, as customer mix continues to shift towards lower-cost options.
Overweight rating and $3.95 target retained.
This report was published on March 23, 2026.
Target price is $3.95 Current Price is $4.03 Difference: minus $0.08 (current price is over target).
If TPG meets the Jarden target it will return approximately minus 2% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $4.04, suggesting downside of -0.8%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 7.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 51.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.1, implying annual growth of 31.7%.
Current consensus DPS estimate is 19.0, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 44.7.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 10.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 37.31.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.2, implying annual growth of 23.1%.
Current consensus DPS estimate is 20.0, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 36.3.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
WES WESFARMERS LIMITED
Consumer Products & Services – Overnight Price: $73.13
Jarden rates ((WES)) as Underweight (4) –
Jarden highlights AI and replacement cycles as potential upside drivers for IT and consumer electronics demand, despite a challenging macro backdrop.
Replacement activity is expected to add 6%-9% to sales, with peak demand expected across FY26–FY27.
The broker believes OEM price increases, particularly from memory cost inflation, may support sales growth, though volume risks remain from higher prices.
Upside potential is strongest for JB Hi-Fi and Harvey Norman, according to Jarden, with AI adoption and device proliferation supporting multi-year demand growth.
The broker also expects Wesfarmers, via Officeworks, and Breville Group to benefit.
Target of $77.30 and Underweight rating are kept for Wesfarmers.
This report was published on March 23, 2026.
Target price is $77.30 Current Price is $73.13 Difference: $4.17
If WES meets the Jarden target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $86.26, suggesting upside of 17.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 223.00 cents and EPS of 256.00 cents.
At the last closing share price the estimated dividend yield is 3.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.57.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 249.8, implying annual growth of -3.2%.
Current consensus DPS estimate is 210.0, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 29.5.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 249.00 cents and EPS of 284.00 cents.
At the last closing share price the estimated dividend yield is 3.40%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 270.8, implying annual growth of 8.4%.
Current consensus DPS estimate is 232.0, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 27.2.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: A11 - ATLANTIC LITHIUM LIMITED.
For more info SHARE ANALYSIS: A2M - A2 MILK COMPANY LIMITED
For more info SHARE ANALYSIS: ALL - ARISTOCRAT LEISURE LIMITED
For more info SHARE ANALYSIS: ARX - AROA BIOSURGERY LIMITED
For more info SHARE ANALYSIS: AUE - AURUM RESOURCES LIMITED
For more info SHARE ANALYSIS: BRG - BREVILLE GROUP LIMITED
For more info SHARE ANALYSIS: BTL - BEETALOO ENERGY AUSTRALIA LIMITED
For more info SHARE ANALYSIS: BTR - BRIGHTSTAR RESOURCES LIMITED
For more info SHARE ANALYSIS: CNB - CARNABY RESOURCES LIMITED
For more info SHARE ANALYSIS: CTM - CENTAURUS METALS LIMITED
For more info SHARE ANALYSIS: HVN - HARVEY NORMAN HOLDINGS LIMITED
For more info SHARE ANALYSIS: JBH - JB HI-FI LIMITED
For more info SHARE ANALYSIS: LNW - LIGHT & WONDER INC
For more info SHARE ANALYSIS: MAF - MA FINANCIAL GROUP LIMITED
For more info SHARE ANALYSIS: MYR - MYER HOLDINGS LIMITED
For more info SHARE ANALYSIS: PME - PRO MEDICUS LIMITED
For more info SHARE ANALYSIS: PMV - PREMIER INVESTMENTS LIMITED
For more info SHARE ANALYSIS: PRU - PERSEUS MINING LIMITED
For more info SHARE ANALYSIS: SM1 - SYNLAIT MILK LIMITED
For more info SHARE ANALYSIS: SNZ - SUMMERSET GROUP HOLDINGS LIMITED
For more info SHARE ANALYSIS: TPG - TPG TELECOM LIMITED
For more info SHARE ANALYSIS: WES - WESFARMERS LIMITED